Univariate analysis of immunohistochemical markers of 3-year progression-free survival and 3-year overall survival of NECC patients in the external validation cohort (N = 122).
posted on 2024-01-05, 18:40authored byCaixian Yu, Xiaoliu Wu, Shao Zhang, Lan Zhang, Hongping Zhang, Hongying Yang, Min Zhao, Zheng Li
Univariate analysis of immunohistochemical markers of 3-year progression-free survival and 3-year overall survival of NECC patients in the external validation cohort (N = 122).